National Symposium 2014

215 - Polycystic Kidney Disease

Apr 15, 2014 12:00pm ‐ Apr 15, 2014 1:15pm

Standard: $20.00
Members: $0.00

Description

Contact hours available until 4/16/2016.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation.

Speaker, Faculty, Planners and Authors Conflict of Interest Disclosure:
Charles Edelstein – Grant/Research Support, Veterans Affairs, American Heart Association; Advisory Board, Conatus Pharmaceuticals

Planning Committee:
• Annette Hood discloses that she is a member of the Amgen speakers’ bureau.
• Denise Murcek discloses other financial/material support as an employee of the VA Medical Center.
• Elizabeth St. John discloses other financial/material support as an employee of Fresenius Medical Care.
• Kyra Trappett discloses other financial/material support as an employee of DaVita.

Commercial Support and Sponsorship:
No commercial support or sponsorship declared.

Accreditation Statement:
American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.

Objectives:
• Describe the genetic etiology of polycystic kidney disease (PKD).
• Differentiate among incidence, prevalence, and progression of autosomal dominant versus recessive PKD.
• Discuss therapeutic management of individuals with autosomal dominant PKD.

Speaker(s):

You must be logged in and own this session in order to post comments.